Abstract
Clinical meaningfulness of the hidradenitis suppurativa clinical response endpoint to assess inflammation and treatment response in 2 phase 3, randomized, placebo-controlled trials (PIONEER I & II)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have